Gain Insights on Minimizing GMP Transition Risks in Media Manufacturing with Upcoming Xtalks Webinar

Upcoming Webinar: Strategies for Reducing GMP Transition Risks in Media Manufacturing



In the ever-evolving landscape of biotech and pharmaceuticals, navigating the transition from non-Good Manufacturing Practices (GMP) to GMP can be fraught with challenges. To address these issues, Xtalks is hosting a complimentary webinar where industry professionals can gain valuable insights on minimizing GMP transition risks in media manufacturing.

Understanding GMP Transition Risks



As organizations move from preliminary development phases into full-scale GMP production, they often encounter specific risks that could impact their timelines, operational consistency, and compliance with regulatory standards. The upcoming webinar aims to provide attendees with a comprehensive understanding of these risks and how to effectively manage them through integrated custom media development.

Taking place on May 12, 2026, this session will be led by Albert Cheong, the Sales Manager for Korea and Head of Media Development Lab at Lonza Bioscience Singapore. With his extensive experience, Cheong will discuss best practices to align non-GMP prototyping with GMP-compliant manufacturing.

Key Takeaways from the Webinar



The webinar will cover a range of topics that are critical for those involved in the media manufacturing sector:
  • - Aligning Prototyping with GMP: Strategies to ensure that early product prototypes meet GMP standards, thus facilitating a smoother transition into full-scale production.
  • - Protecting Proprietary Formulations: Guidance on safeguarding intellectual property while complying with GMP requirements.
  • - Long-Term Supply Continuity: Insights into maintaining consistent supply across global manufacturing sites, even amidst fluctuating demands and regulatory changes.
  • - Real-World Examples: Cheong will share practical case studies demonstrating how integrated strategies have improved flexibility, reduced risks, and accelerated time-to-market for various products.

Why Attend?



This webinar is an excellent opportunity for professionals in biotech, pharmaceuticals, and related fields seeking to strengthen their knowledge of media manufacturing processes compliant with GMP. The insights gained will be valuable for those looking to streamline their operations while minimizing risks and ensuring compliance.

Attendees will also have the chance to engage in a Q&A session, enabling them to receive direct responses to their queries from Cheong and other industry experts.

Register Today!



To secure your spot in this insightful event, visit the Xtalks website and register for the 'Media Manufacturing Strategies to Reduce GMP Transition Risks' webinar. Engage with peers and stay ahead of industry challenges through the knowledge shared in this comprehensive session. Whether you’re part of a large corporation or a burgeoning startup, understanding GMP transition risks will help fortify your production pipeline for years to come.

Join us on May 12, and get ready to elevate your media manufacturing strategies!

For more information about this and other upcoming webinars, check out Xtalks—your trusted resource for industry news and developments.

  • ---

About Xtalks



Xtalks is an essential platform for professionals in the life sciences sector, offering resources, webinars, and collaborations designed to keep you informed and ahead of the curve. Powered by Honeycomb Worldwide Inc., Xtalks is dedicated to facilitating knowledge sharing that leads to informed decision-making within the rapidly evolving landscape of biotech, pharma, and healthcare.

Topics Consumer Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.